MAPK10 and cancer: We observed that when HCC patients were grouped by the transcriptomically defined immune activity of the liver cancer microenvironment, the lower immune activity correlated with lower MAPK10 expression, reduced scores of tumor infiltration lymphocytes (TILs) and stromal cells, but increased scores of cancer cells (Figure 3A).